دورية أكاديمية
POPDC1 scaffolds a complex of adenylyl cyclase 9 and the potassium channel TREK-1 in heart.
العنوان: | POPDC1 scaffolds a complex of adenylyl cyclase 9 and the potassium channel TREK-1 in heart. |
---|---|
المؤلفون: | Baldwin TA; Department Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Li Y; Department Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Marsden AN; Department Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Rinné S; Institute for Physiology and Pathophysiology, Vegetative Physiology and Marburg Center for Mind, Brain and Behavior MCMBB, Philipps-University of Marburg, Marburg, Germany., Garza-Carbajal A; Department Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Schindler RFR; National Heart and Lung Institute, Imperial College London, London, UK., Zhang M; Department Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Garcia MA; Department Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Venna VR; Department Neurology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Decher N; Institute for Physiology and Pathophysiology, Vegetative Physiology and Marburg Center for Mind, Brain and Behavior MCMBB, Philipps-University of Marburg, Marburg, Germany., Brand T; National Heart and Lung Institute, Imperial College London, London, UK., Dessauer CW; Department Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA. |
المصدر: | EMBO reports [EMBO Rep] 2022 Dec 06; Vol. 23 (12), pp. e55208. Date of Electronic Publication: 2022 Oct 18. |
نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2024- : [London] : Nature Publishing Group Original Publication: Oxford, UK : Published for EMBO by Oxford University Press, 2000- |
مواضيع طبية MeSH: | Adenylyl Cyclases*/genetics , Potassium Channels* |
مستخلص: | The establishment of macromolecular complexes by scaffolding proteins is key to the local production of cAMP by anchored adenylyl cyclase (AC) and the subsequent cAMP signaling necessary for cardiac functions. We identify a novel AC scaffold, the Popeye domain-containing (POPDC) protein. The POPDC family of proteins is important for cardiac pacemaking and conduction, due in part to their cAMP-dependent binding and regulation of TREK-1 potassium channels. We show that TREK-1 binds the AC9:POPDC1 complex and copurifies in a POPDC1-dependent manner with AC9 activity in heart. Although the AC9:POPDC1 interaction is cAMP-independent, TREK-1 association with AC9 and POPDC1 is reduced upon stimulation of the β-adrenergic receptor (βAR). AC9 activity is required for βAR reduction of TREK-1 complex formation with AC9:POPDC1 and in reversing POPDC1 enhancement of TREK-1 currents. Finally, deletion of the gene-encoding AC9 (Adcy9) gives rise to bradycardia at rest and stress-induced heart rate variability, a milder phenotype than the loss of Popdc1 but similar to the loss of Kcnk2 (TREK-1). Thus, POPDC1 represents a novel adaptor for AC9 interactions with TREK-1 to regulate heart rate control. (©2022 The Authors. Published under the terms of the CC BY 4.0 license.) |
References: | Annu Rev Pharmacol Toxicol. 2013;53:187-210. (PMID: 23043438) Proteomics. 2017 Sep;17(17-18):. (PMID: 28755400) Onco Targets Ther. 2019 Feb 18;12:1279-1291. (PMID: 30863095) Trends Pharmacol Sci. 2020 Dec;41(12):933-946. (PMID: 33082006) Biochem Soc Trans. 2019 Oct 31;47(5):1393-1404. (PMID: 31551355) Circ Cardiovasc Genet. 2013 Aug;6(4):362-71. (PMID: 23863953) Brain Behav Immun. 2013 Oct;33:164-72. (PMID: 23886782) Oral Dis. 2015 Jan;21(1):e25-50. (PMID: 25056711) Mol Biol Cell. 2015 Nov 1;26(21):3777-87. (PMID: 26337391) Elife. 2016 May 10;5:. (PMID: 27162171) Front Physiol. 2018 Nov 09;9:1548. (PMID: 30473666) Neuromuscul Disord. 2020 Aug;30(8):674-679. (PMID: 32684383) Cells. 2019 Aug 27;8(9):. (PMID: 31461851) J Clin Invest. 2012 Mar;122(3):1119-30. (PMID: 22354168) Mol Pharmacol. 2019 Apr;95(4):349-360. (PMID: 30696718) Mol Pharmacol. 2009 Nov;76(5):935-41. (PMID: 19684092) Biochem Soc Trans. 2014 Apr;42(2):295-301. (PMID: 24646234) J Biol Chem. 2010 May 7;285(19):14450-8. (PMID: 20231277) J Mol Cell Cardiol. 2022 Apr;165:86-102. (PMID: 34999055) Cardiovasc Res. 2007 Jul 1;75(1):59-68. (PMID: 17389142) Circ Res. 2015 Feb 27;116(5):797-803. (PMID: 25623957) Elife. 2020 Jun 09;9:. (PMID: 32515353) EMBO J. 2006 Dec 13;25(24):5864-72. (PMID: 17110924) Channels (Austin). 2007 Mar-Apr;1(2):124-34. (PMID: 18690021) Biochem Soc Trans. 2019 Dec 20;47(6):1749-1756. (PMID: 31769471) J Biol Chem. 2008 May 23;283(21):14461-8. (PMID: 18356168) J Biol Chem. 2009 Aug 28;284(35):23540-6. (PMID: 19574217) Psychopharmacology (Berl). 2005 Jan;177(3):245-55. (PMID: 15609067) J Muscle Res Cell Motil. 2019 Jun;40(2):169-183. (PMID: 31197601) Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13835-40. (PMID: 18772391) J Neurosci Methods. 1985 Aug;14(3):149-67. (PMID: 2864480) Mol Cell Biol. 2002 Mar;22(5):1504-12. (PMID: 11839816) Cell. 2015 Jul 16;162(2):425-440. (PMID: 26186194) Trends Pharmacol Sci. 2018 Feb;39(2):209-222. (PMID: 29289379) Nat Biotechnol. 2002 May;20(5):473-7. (PMID: 11981560) Sci Rep. 2017 Jul 17;7(1):5522. (PMID: 28717248) Mol Pharmacol. 2018 Apr;93(4):270-276. (PMID: 29217670) J Cardiovasc Dev Dis. 2018 Jan 16;5(1):. (PMID: 29367580) J Clin Invest. 2016 Jan;126(1):239-53. (PMID: 26642364) EMBO Rep. 2022 Dec 6;23(12):e55208. (PMID: 36254885) J Cardiovasc Dev Dis. 2016 Jun 15;3(2):. (PMID: 27347491) Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H95-H107. (PMID: 33064562) J Mol Cell Cardiol. 2012 Jun;52(6):1233-9. (PMID: 22484253) J Mol Cell Cardiol. 2020 Aug;145:74-83. (PMID: 32535041) Life Sci. 2014 Mar 3;97(2):107-15. (PMID: 24345461) PLoS One. 2013 Sep 16;8(9):e71100. (PMID: 24066022) Cardiovasc Res. 2014 Apr 1;102(1):166-75. (PMID: 24445605) Front Neurosci. 2019 Jun 18;13:615. (PMID: 31275103) J Am Heart Assoc. 2016 Apr 20;5(4):e002865. (PMID: 27098968) Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9769-74. (PMID: 26195795) PLoS One. 2008 May 21;3(5):e2261. (PMID: 18493308) Cell. 2022 Mar 31;185(7):1130-1142.e11. (PMID: 35294858) J Biol Chem. 2012 Aug 24;287(35):29815-24. (PMID: 22778270) Prog Biophys Mol Biol. 2016 Jan;120(1-3):28-36. (PMID: 26772438) Int J Mol Med. 2011 Jan;27(1):25-31. (PMID: 21069264) J Biol Chem. 2010 Jun 25;285(26):20328-42. (PMID: 20410303) Prog Biophys Mol Biol. 2021 Nov;166:22-28. (PMID: 32853595) J Physiol. 2007 Aug 1;582(Pt 3):1195-203. (PMID: 17540702) J Biol Chem. 2013 Feb 8;288(6):3929-37. (PMID: 23264624) Prog Biophys Mol Biol. 2021 Jan;159:126-135. (PMID: 32553901) Dev Biol. 2012 Mar 15;363(2):438-50. (PMID: 22290329) Channels (Austin). 2011 Sep-Oct;5(5):402-9. (PMID: 21829087) PLoS One. 2011 Jan 20;6(1):e14563. (PMID: 21283798) J Cell Sci. 2012 Dec 1;125(Pt 23):5850-9. (PMID: 22976297) Circ Res. 2001 Aug 17;89(4):336-42. (PMID: 11509450) Ann Neurol. 2019 Dec;86(6):832-843. (PMID: 31610034) Nature. 2017 Jul 20;547(7663):364-368. (PMID: 28693035) Cell Signal. 2017 Dec;40:156-165. (PMID: 28939104) Front Behav Neurosci. 2018 Apr 03;12:58. (PMID: 29670513) |
معلومات مُعتمدة: | R35 GM145291 United States GM NIGMS NIH HHS; PG/19/13/34247 United Kingdom BHF_ British Heart Foundation; PG/14/46/30911 United Kingdom BHF_ British Heart Foundation; R01 GM060419 United States GM NIGMS NIH HHS; R37 NS096493 United States NS NINDS NIH HHS |
فهرسة مساهمة: | Keywords: ADCY9; BVES; TREK-1; adenylyl cyclase; heart rate variability |
المشرفين على المادة: | EC 4.6.1.1 (Adenylyl Cyclases) 0 (Potassium Channels) |
تواريخ الأحداث: | Date Created: 20221018 Date Completed: 20221215 Latest Revision: 20230621 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC9724675 |
DOI: | 10.15252/embr.202255208 |
PMID: | 36254885 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1469-3178 |
---|---|
DOI: | 10.15252/embr.202255208 |